INFECTIOUS DISEASES (ID) -> ID - Heart Abstracts

88 - Preliminary Results of a Randomized Clinical Trial of Intravenous Immunoglobulin in Solid Organ Recipients with Severe Infection and Secondary Antibody Deficiency

Presentation Number
88
Speakers
Session Name
SESSION 26 - ORAL: Identification and Mitigation of Infectious Threats in Cardiothoracic Transplantation
Date
Thu, Apr 23, 2020
Time
08:15 AM - 10:00 AM
Authors
Audio Upload

Previous ePresentation
85 - Impact of Prophylactic Donor Heart Tricuspid Valve Annuloplasty in Long-Term Clinical Outcomes of Heart Transplantation

Next ePresentations
100 - Novel Methods for Donor and Recipient Size Matching in Heart Transplantation
103 - Pulmonary Vascular Resistances among Heart Transplant Candidates: Are We Looking to the Right Player?
108 - Hemodynamic Effects of Sacubitril-Valsartan in Heart Failure with Reduced-Ejection Fraction: Are All Doses Created Equal?
110 - Impact of Immunosuppression on Acute Left Ventricular Function Recovery and ECMO Use in Patients with Fulminant Viral Myocarditis: An “All-In” Strategy
121 - Mapping the Injury Phenotypes of Heart Transplant
123 - Upregulation of Class II HLA as a Marker of Antibody-Mediated Rejection in Heart Allografts
148 - Development and Utility of a Novel Post-Operative Pediatric Heart Transplant Clinical Pathway
161 - The Impact of Local Heart Allocation on Post-Transplant Survival
163 - Early IVUS-Guided Selection for Non-Invasive Cardiac Allograft Vasculopathy (CAV) Screening in Heart Transplant Recipients
168 - Assessment of Cardiac Allograft Vasculopathy from Oct Images: Automated Analysis is as Good as Expert-Guided Approach